HHMI
CALA

Howard Hughes Medical Institute’s Calithera Biosciences, Inc CALA Stock Holding History

Howard Hughes Medical Institute’s Portfolio CALA Stock Details CALA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-162
Closed -$48K – 134
2017
Q2 		$48K Buy
+162
New +$43.3K 0.01% 151

Other funds holding CALA

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
AC
Ascend Capital Orinda, California $1.99B AUM 10.36% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return

Howard Hughes Medical Institute's CALA Position: Q3 2017 in Review

Howard Hughes Medical Institute sold out of Calithera Biosciences, Inc (CALA) in Q3 2017, closing a stake of 162 shares — an estimated $48K sold.

Howard Hughes Medical Institute first reported a position in CALA in Q2 2017 and held it in 1 quarter. The position peaked at $48K in Q2 2017. 91 funds tracked by Wall St. Rank hold CALA as of Q3 2017.

  • Howard Hughes Medical Institute reported no remaining Calithera Biosciences, Inc position as of Q3 2017 after selling out during the quarter.
  • Howard Hughes Medical Institute sold 162 Calithera Biosciences, Inc shares in Q3 2017, an estimated $48K.
  • Howard Hughes Medical Institute first reported a position in Calithera Biosciences, Inc in Q2 2017 and held it in 1 quarter.
  • Howard Hughes Medical Institute's Calithera Biosciences, Inc position peaked at $48K in Q2 2017.
  • 91 funds tracked by Wall St. Rank held Calithera Biosciences, Inc as of Q3 2017.

Based on Howard Hughes Medical Institute's 13F filing for Q3 2017, filed 2 Nov 2017.